Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 6
109
Views
6
CrossRef citations to date
0
Altmetric
Short Communications

α-Mangostin exhibits antidepressant-like effects mediated by the modification of GABAergic, serotonergic and dopaminergic systems

, , , , , , , & show all
Pages 868-871 | Received 27 Jan 2018, Accepted 18 Jul 2018, Published online: 10 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Khairy A. Ibrahim, Mohammed Eleyan, Soad A. Khwanes, Rania A. Mohamed & Basim M. Ayesh. (2022) Alpha-mangostin attenuates the apoptotic pathway of abamectin in the fetal rats’ brain by targeting pro-oxidant stimulus, catecholaminergic neurotransmitters, and transcriptional regulation of reelin and nestin. Drug and Chemical Toxicology 45:6, pages 2496-2508.
Read now

Articles from other publishers (5)

Luthfi Utami Setyawati, Wiwit Nurhidayah, Nur Kusaira Khairul Ikram, Wan Ezumi Mohd Fuad & Muchtaridi Muchtaridi. (2023) General toxicity studies of alpha mangostin from Garcinia mangostana: A systematic review. Heliyon 9:5, pages e16045.
Crossref
Atefeh Jalali, Negar Firouzabadi & Mohammad M. Zarshenas. (2021) Pharmacogenetic‐based management of depression: Role of traditional Persian medicine. Phytotherapy Research 35:9, pages 5031-5052.
Crossref
Łucja Justyna Walczak-Nowicka & Mariola Herbet. (2021) Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis. International Journal of Molecular Sciences 22:17, pages 9290.
Crossref
Aarti Tiwari, Rishabh Khera, Saloni Rahi, Sidharth Mehan, Hafiz Antar Makeen, Yahya H. Khormi, Muneeb U Rehman & Andleeb Khan. (2021) Neuroprotective Effect of α-Mangostin in Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats. Brain Sciences 11:3, pages 288.
Crossref
Ha Thi Thu Do & Jungsook Cho. (2020) Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer’s Disease, Parkinson’s Disease, and Depression with Pharmacokinetic and Safety Profiles. International Journal of Molecular Sciences 21:17, pages 6211.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.